First Alzheimer’s drug shown to modestly slow cognitive decline gets full FDA approval

by | Jul 6, 2023 | Uncategorized

Japanese drugmaker Eisai’s Leqembi is priced at about $26,500 for a year’s supply of IVs every two weeks. Read More